Basic Research
Copyright ©2006 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. May 21, 2006; 12(19): 3060-3064
Published online May 21, 2006. doi: 10.3748/wjg.v12.i19.3060
Effect of early administration of exogenous basic fibroblast growth factor on acute edematous pancreatitis in rats
Qiang Yan, Xing Yao, Li-Cheng Dai, Guo-Lei Zhang, Jin-Liang Ping, Jian-Fang He, Chun-Fan Han
Qiang Yan, Xing Yao, Li-Cheng Dai, Guo-Lei Zhang, Jin-Liang Ping, Jian-Fang He, Chun-Fan Han, Department of Hepatobiliary and Pancreatic Surgery, Huzhou Central Hospital, Huzhou 313000, Zhejiang Province, China
Co-first-authors: Qiang Yan and Xing Yao
Co-correspondence: Li-Cheng Dai
Correspondence to: Dr. Qiang Yan, Huzhou Central Hospital, 198 Red Flag Road, Huzhou 313000, Zhejiang Province, China. yanqiang@ppp.huptt.zj.cn
Telephone: +86-572-2023301-2112 Fax: +86-572-2023219
Received: November 2, 2005
Revised: December 12, 2005
Accepted: December 22, 2005
Published online: May 21, 2006
Abstract

AIM: To observe the therapeutic effect of early administration of exogenous Basic fibroblast growth factor (bFGF) on acute edematous pancreatitis (AEP) in rats.

METHODS: Thirty male Sprague-Dawley rats were randomly divided into three (n = 10): normal control group (group I), AEP group (group II) and AEP with bFGF treatment group (group III). AEP was induced by subcutaneous injection of cerulein (5.5 μg/kg and 7.5 μg/kg) at 1 h interval into rats of groups II and III. Three hours after induction of AEP, 100 μg/kg bFGF was administrated intraperitoneally for 1h to group III rats. For test of DNA synthesis in acinar cells, 5-bromo-2’-deoxyuridine (BrdU) labeling solution was intraperitoneally injected into the rats of groups II and III 24 h after bFGF treatment. The changes in serum amylase, lipase, pancreatic tissue wet/dry ratio were detected.

RESULTS: In bFGF treatment group, there was a significant decrease in the volume of serum amylase, lipase and the pancreatic wet/dry weight ratio(1383.0 ± 94.6 U/L, 194.0 ± 43.6 U/L, 4.32 ± 0.32) compared to AEP group (3464 ± 223.7 U/L, 456 ±68.7 U/L, 6.89 ± 0.47) (P < 0.01), and no significant difference was found between bFGF treatment and control group (1289 ± 94.0 U/L, 171 ± 23.4 U/L, 4.12 ± 0.26, P > 0.05). The inflammatory changes such as interstitial edema, polymorphonuclear neutrophils (PMNs) and vacuolization were significantly ameliorated compared to AEP group (P < 0.01). A small number of BrdU-labeled nuclei were observed in acinar cells of AEP rats (1.8 ± 0.3 nuclei/microscopic field, n = 10) while diffuse BrdU-labeled nuclei were found in bFGF-treated rats (18.9 ± 1.4 nuclei/microscopic field, n = 10) (P < 0.01). Immunohistochemical study showed increased DNA synthesis in pancreatic acinar cells.

CONCLUSION: Early administration of exogenous bFGF has significant therapeutic effect on cerulein-induced acute edematous pancreatitis in rats. Its mechanism is related to the amelioration of inflammation and facilitation of pancreatic regeneration.

Keywords: Basic fibroblast growth factor; Acute edematous pancreatitis; Cerulein